Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014;10(6):1725-8.
doi: 10.4161/hv.28206. Epub 2014 Mar 7.

Meningococcal serogroup Y emergence in Europe: high importance in some European regions in 2012

Affiliations

Meningococcal serogroup Y emergence in Europe: high importance in some European regions in 2012

Michael Bröker et al. Hum Vaccin Immunother. 2014.

Abstract

Neisseria meningitidis is differentiated into 12 distinct serogroups, of which A, B, C, W, X, and Y are medically most important and represent an important health problem in different parts of the world. The epidemiology of N. meningitidis is unpredictable over time and across geographic regions. Recent epidemiological surveillance has indicated an increase of serogroup Y invasive meningococcal disease in some parts of Europe as shown in the epidemiological data for 2010 and 2011 from various European countries previously published in this journal. (1)(,) (2) Here, data from 33 European countries is reported indicating that the emergence of serogroup Y continued in 2012 in various regions of Europe, especially in Scandinavia, while in Eastern and South-Eastern Europe the importance of serogroup Y remained low.

Keywords: Europe; epidemiology; invasive meningococcal disease; meningococcal vaccines; serogroup Y; surveillance.

PubMed Disclaimer

Figures

None
Figure 1. Relative proportion of N. meningitidis serogroup Y in various European countries in 2012. The figure is based on data communicated by the scientists listed in the Acknowledgment and/or published in web pages of national public institutes. The data for 2012 are compared with data from 2010 and 2011, which have been communicated earlier., Color coding refers 2012 data. Data were not available to the authors for countries shown in white.

References

    1. Bröker M, Jacobsson S, DeTora L, Pace D, Taha M-K. Increase of meningococcal serogroup Y cases in Europe: a reason for concern? Hum Vaccin Immunother. 2012;8:685–8. doi: 10.4161/hv.20098. - DOI - PubMed
    1. Bröker M, Jacobsson S, Kuusi M, Pace D, Simões MJ, Skoczynska A, Taha MK, Toropainen M, Tzanakaki G. Meningococcal serogroup Y emergence in Europe: update 2011. Hum Vaccin Immunother. 2012;8:1907–11. doi: 10.4161/hv.21794. - DOI - PMC - PubMed
    1. Vyse A, Anonychuk A, Jäkel A, Wieffer H, Nadel S. The burden and impact of severe and long-term sequelae of meningococcal disease. Expert Rev Anti Infect Ther. 2013;11:597–604. doi: 10.1586/eri.13.42. - DOI - PubMed
    1. Anonychuk A, Woo G, Vyse A, Demarteau N, Tricco AC. The cost and public health burden of invasive meningococcal disease outbreaks: a systematic review. Pharmacoeconomics. 2013;31:563–76. doi: 10.1007/s40273-013-0057-2. - DOI - PMC - PubMed
    1. European Union Invasive Bacterial Infections Surveillance (EU-IBIS) Network. Invasive Neisseria meningitidis in Europe 2006. Health Protection Agency, London 2006. Available from http://www.cuibis.org

MeSH terms

LinkOut - more resources